Answers are grounded in this paper and cite their sources.
The human skin blanching assay remains in widespread use as a reliable, qualitative, comparative indicator of topical corticosteroid availability and potency. The experimental refinements promulgated by certain researchers in this field have yielded a versatile bioassay for the accurate assessment of new drugs or delivery vehicles. With the increasing appearance of generic topical corticosteroid formulations which compete with trade-oame equivalents, the vital importance of this assay in regulatory affairs and assessing bioequivalence has been re-emphasized. It is stressed that if the blanching assay is to be used in this sphere, then multiplereading trials must be conducted; important registration or clinical decisions cannot be made with any validity from short-term assessments.
No takes yet. Share an insight, caveat, or question.
Smith et al. (1991) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: